Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

VP6: A candidate rotavirus vaccine.

Ward RL, McNeal MM.

J Infect Dis. 2010 Sep 1;202 Suppl:S101-7. doi: 10.1086/653556. Review.

PMID:
20684688
3.

Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses.

Choi AH, McNeal MM, Basu M, Flint JA, Stone SC, Clements JD, Bean JA, Poe SA, VanCott JL, Ward RL.

Vaccine. 2002 Sep 10;20(27-28):3310-21.

PMID:
12213401
4.

Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge.

McNeal MM, Basu M, Bean JA, Clements JD, Lycke NY, Ramne A, Löwenadler B, Choi AH, Ward RL.

Vaccine. 2007 Aug 14;25(33):6224-31. Epub 2007 Jun 21.

PMID:
17629371
5.

Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies.

García-Díaz A, López-Andújar P, Rodríguez Díaz J, Montava R, Torres Barceló C, Ribes JM, Buesa J.

Vaccine. 2004 Dec 9;23(4):489-98.

PMID:
15530697
6.

Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates.

VanCott JL, Prada AE, McNeal MM, Stone SC, Basu M, Huffer B Jr, Smiley KL, Shao M, Bean JA, Clements JD, Choi AH, Ward RL.

J Virol. 2006 May;80(10):4949-61.

7.

Development of a Bacillus subtilis-based rotavirus vaccine.

Lee S, Belitsky BR, Brinker JP, Kerstein KO, Brown DW, Clements JD, Keusch GT, Tzipori S, Sonenshein AL, Herrmann JE.

Clin Vaccine Immunol. 2010 Nov;17(11):1647-55. doi: 10.1128/CVI.00135-10. Epub 2010 Sep 1.

8.

Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA.

McNeal MM, Stone SC, Basu M, Bean JA, Clements JD, Hendrickson BA, Choi AH, Ward RL.

Virology. 2006 Mar 15;346(2):338-47. Epub 2006 Jan 10.

9.

Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice.

Choi AH, Basu M, McNeal MM, Bean JA, Clements JD, Ward RL.

Protein Expr Purif. 2004 Dec;38(2):205-16. Erratum in: Protein Expr Purif. 2007 May;53(1):238.

PMID:
15555936
10.

Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine.

Dennehy M, Bourn W, Steele D, Williamson AL.

Vaccine. 2007 May 4;25(18):3646-57. Epub 2007 Jan 31.

PMID:
17339069
11.

Identification of an immunodominant CD4+ T cell epitope in the VP6 protein of rotavirus following intranasal immunization of BALB/c mice.

McNeal MM, Basu M, Bean JA, Clements JD, Choi AH, Ward RL.

Virology. 2007 Jul 5;363(2):410-8. Epub 2007 Mar 6.

12.
13.

Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.

Badillo-Godinez O, Gutierrez-Xicotencatl L, Plett-Torres T, Pedroza-Saavedra A, Gonzalez-Jaimes A, Chihu-Amparan L, Maldonado-Gama M, Espino-Solis G, Bonifaz LC, Esquivel-Guadarrama F.

Vaccine. 2015 Aug 20;33(35):4228-37. doi: 10.1016/j.vaccine.2015.03.080. Epub 2015 Apr 4.

PMID:
25850020
14.

The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant.

Choi AH, McNeal MM, Flint JA, Basu M, Lycke NY, Clements JD, Bean JA, Davis HL, McCluskie MJ, VanCott JL, Ward RL.

Vaccine. 2002 Mar 15;20(13-14):1733-40.

PMID:
11906760
16.

Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine.

Lappalainen S, Pastor AR, Malm M, López-Guerrero V, Esquivel-Guadarrama F, Palomares LA, Vesikari T, Blazevic V.

Arch Virol. 2015 Aug;160(8):2075-8. doi: 10.1007/s00705-015-2461-8. Epub 2015 May 29.

17.
18.

The assembly conformation of rotavirus VP6 determines its protective efficacy against rotavirus challenge in mice.

Pastor AR, Rodríguez-Limas WA, Contreras MA, Esquivel E, Esquivel-Guadarrama F, Ramírez OT, Palomares LA.

Vaccine. 2014 May 19;32(24):2874-7. doi: 10.1016/j.vaccine.2014.02.018. Epub 2014 Feb 25.

PMID:
24583002
20.

IFN-gamma is the only anti-rotavirus cytokine found after in vitro stimulation of memory CD4+ T cells from mice immunized with a chimeric VP6 protein.

McNeal MM, Stone SC, Basu M, Clements JD, Choi AH, Ward RL.

Viral Immunol. 2007 Dec;20(4):571-84.

PMID:
18158731

Supplemental Content

Support Center